DEVELOPMENT OF RATIOMETRIC IMAGING PROBE SYSTEM FOR MONITORING INFLAMMATION
用于监测炎症的比率成像探头系统的开发
基本信息
- 批准号:8312911
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2014-02-14
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAdoptedAffectAnimalsArthritisAsthmaBiocompatibleBiocompatible MaterialsBiopsyBloodBurn injuryCellsClinicalDendritic CellsDetectionDevelopmentDevicesDiagnosisDiseaseDyesElectron Spin Resonance SpectroscopyEnzyme-Linked Immunosorbent AssayEvaluationFluorescent DyesGoalsGunshot woundHandHumanHyaluronic AcidHydrogen PeroxideImageImmuneIn SituIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjuryInvestigationLinkLuminolLymphocyteMalignant NeoplasmsMeasurementMediatingMethodsModelingMonitorMyocardial InfarctionOpticsPathogenesisPatient CarePatientsProceduresProcessProductionReactionReactive Oxygen SpeciesRecruitment ActivityRespiratory BurstRoleSeriesSignal TransductionSiteSourceStimulusSuperoxidesSyndromeSystemTechniquesTestingTimeTissuesTraumaVariantWhite Blood Cell Count procedureWorkWound Healingbasecytokinedesignimaging probeimprovedin vitro activityin vivoinjuredkillingsmacrophagemast cellmicroorganismmonocytenanoparticleneutrophilnon-invasive monitornoveloxidative damageparticleratiometricsensorsubcutaneoustoolwound
项目摘要
DESCRIPTION (provided by applicant): Inflammation is a major unifying syndrome associated with a variety of injury and diseases. When severe, inflammatory diseases can endanger and even kill patients. Direct diagnosis of the extent of inflammatory responses is often made histological with an invasive biopsy. Furthermore, multiple biopsies are often required to assess the extent of inflammatory reactions in a large wound. The proposed work is aimed at developing a new non-invasive method to assess the extent of inflammatory responses in real-time in vivo. Reactive oxygen species (ROS) released by polymorphonuclear neutrophils have been shown to be a good indicator of the degree of inflammatory reactions. Several ROS-reactive bioluminescent probes have been investigated in recent years to detect ROS activities in vivo. Unfortunately, these probes alone cannot be used to quantify the degree of inflammatory responses due to the fact that the extent of the bioluminescent signals is also probe-concentration dependent. To address this challenge, we adopt ratiometric probe technique in which both ROS-sensitive agents and ROS-insensitive reference dye are conjugated to biocompatible particle carriers. The bioluminescent/reference fluorescent intensity ratios can be calculated to reflect the extent of localized ROS activities while circumventing the variations of bioluminescent intensities associated with the ROS probe concentrations. Our preliminary studies have led to the development of ROS ratiometric probes which can reliably detect localized ROS activities in vivo and inflamed tissue in the wound site. Based on these exciting observations, the proposed work will create a series of ROS ratiometric probes to detect ROS activities in vitro (Aim 1) and to assess the extent of inflammatory responses mediated by different injuries or inflammatory stimuli in vivo (Aim 2). Finally, since all commercial imagers are designed with an enclosed chamber only suitable for cell and small animal imaging, a handheld imager for ROS sensing in large animals and human will be developed as part of this investigation. The successful completion of this proposed work will help the development of a new diagnosis tool which can be applied to non-invasively monitor the inflammatory processes in real-time and assist the development of new treatments to effectively reduce inflammation and improve wound healing reactions.
PUBLIC HEALTH RELEVANCE: A series of novel reactive oxygen species (ROS) ratiometric imaging probes and a hand-held optical device will be fabricated to monitor and quantify in situ ROS activities and associated inflammatory responses in vivo. The successful completion of the proposed work will help the development of a new diagnosis tool which can be effectively used to non-invasively assess the extent of inflammatory processes in real-time and substantially improve the quality of patient care.
描述(由申请人提供):炎症是与多种损伤和疾病相关的主要统一综合征。严重时,炎症性疾病会危及甚至杀死患者。炎症反应程度的直接诊断通常通过侵入性活检进行组织学诊断。此外,通常需要进行多次活检来评估大伤口的炎症反应程度。拟议的工作旨在开发一种新的非侵入性方法来实时评估体内炎症反应的程度。多形核中性粒细胞释放的活性氧(ROS)已被证明是炎症反应程度的良好指标。近年来,人们研究了几种 ROS 反应性生物发光探针来检测体内 ROS 活性。不幸的是,由于生物发光信号的程度也依赖于探针浓度,因此这些探针不能单独用于量化炎症反应的程度。为了应对这一挑战,我们采用比例探针技术,其中 ROS 敏感剂和 ROS 不敏感参考染料均与生物相容性颗粒载体缀合。可以计算生物发光/参考荧光强度比,以反映局部 ROS 活性的程度,同时避免与 ROS 探针浓度相关的生物发光强度的变化。我们的初步研究导致了 ROS 比例探针的开发,它可以可靠地检测体内局部 ROS 活性和伤口部位的发炎组织。基于这些令人兴奋的观察结果,拟议的工作将创建一系列ROS比率探针来检测体外ROS活性(目标1)并评估体内不同损伤或炎症刺激介导的炎症反应程度(目标2)。最后,由于所有商业成像仪均设计有仅适用于细胞和小动物成像的封闭室,因此作为本研究的一部分,将开发用于大型动物和人类 ROS 传感的手持式成像仪。这项工作的成功完成将有助于开发一种新的诊断工具,该工具可用于非侵入性地实时监测炎症过程,并协助开发新的治疗方法,以有效减少炎症并改善伤口愈合反应。
公共健康相关性:将制造一系列新型活性氧 (ROS) 比率成像探针和手持式光学设备,以监测和量化原位 ROS 活性和体内相关炎症反应。拟议工作的成功完成将有助于开发一种新的诊断工具,该工具可有效地用于非侵入性地实时评估炎症过程的程度,并大幅提高患者护理的质量。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Canny edge-based deformable image registration.
- DOI:10.1088/1361-6560/aa5342
- 发表时间:2017-02-07
- 期刊:
- 影响因子:3.5
- 作者:Kearney V;Huang Y;Mao W;Yuan B;Tang L
- 通讯作者:Tang L
Ratiometric Reactive Oxygen Species Nanoprobe for Noninvasive In Vivo Imaging of Subcutaneous Inflammation/Infection.
- DOI:10.1166/jbn.2016.2268
- 发表时间:2016-08
- 期刊:
- 影响因子:2.9
- 作者:Zhou J;Weng H;Huang Y;Gu Y;Tang L;Hu W
- 通讯作者:Hu W
Optical imaging of fibrin deposition to elucidate participation of mast cells in foreign body responses.
- DOI:10.1016/j.biomaterials.2013.11.040
- 发表时间:2014-02
- 期刊:
- 影响因子:14
- 作者:Tsai, Yi-Ting;Zhou, Jun;Weng, Hong;Tang, Ewin N.;Baker, David W.;Tang, Liping
- 通讯作者:Tang, Liping
Design of a portable imager for near-infrared visualization of cutaneous wounds.
设计用于皮肤伤口近红外可视化的便携式成像仪。
- DOI:10.1117/1.jbo.22.1.016010
- 发表时间:2017
- 期刊:
- 影响因子:3.5
- 作者:Peng,Zhaoqiang;Zhou,Jun;Dacy,Ashley;Zhao,Deyin;Kearney,Vasant;Zhou,Weidong;Tang,Liping;Hu,Wenjing
- 通讯作者:Hu,Wenjing
Development of a dual-wavelength fluorescent nanoprobe for in vivo and in vitro cell tracking consecutively.
- DOI:10.1016/j.bmc.2019.03.036
- 发表时间:2019-05
- 期刊:
- 影响因子:3.5
- 作者:Hong Vu;Jun Zhou;YiHui Huang;Amirhossein Hakamivala;M. Khang;Liping Tang
- 通讯作者:Hong Vu;Jun Zhou;YiHui Huang;Amirhossein Hakamivala;M. Khang;Liping Tang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wenjing Hu其他文献
Wenjing Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wenjing Hu', 18)}}的其他基金
Multi-functional particles for stem cell isolation and expansion
用于干细胞分离和扩增的多功能颗粒
- 批准号:
8644605 - 财政年份:2014
- 资助金额:
$ 21.96万 - 项目类别:
A novel optical imaging probe system for assessing wound healing and infection
一种用于评估伤口愈合和感染的新型光学成像探针系统
- 批准号:
8591219 - 财政年份:2013
- 资助金额:
$ 21.96万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 21.96万 - 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
- 批准号:
10585773 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
肝脏靶向二氢喹嗪酮 (DHQ) 分子作为乙型肝炎病毒抗病毒药物,毒性降低
- 批准号:
10593566 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别: